YARROW BIOSCIENCE, INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
YARROW BIOSCIENCE, INC. (YARW) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of -$7.53 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2022-03-17
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2020-09-30 was -$0.59.
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2020-06-30 was -$1.21.
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2020-03-31 was -$0.62.
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2019-09-30 was -$0.66.
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2020 was -$7.53.
- YARROW BIOSCIENCE, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2019 was -$11.19.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | -$7.53 10-K · filed 2022-03-17 | |||||
| 2020-09-30 | -$0.59 10-Q · filed 2021-11-10 | -$0.15 10-Q · filed 2020-11-05 | -$7.89 10-Q · filed 2021-11-10 | -$1.88 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | -$1.21 10-Q · filed 2021-08-12 | -$1.23 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | -$0.62 10-Q · filed 2021-05-06 | |||||
| 2019-12-31 | -$11.19 10-K · filed 2021-03-04 | |||||
| 2019-09-30 | -$0.66 10-Q · filed 2020-11-05 | -$1.82 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | -$0.59 10-Q · filed 2020-08-06 | -$1.16 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |